Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine (multiple letters) [1]

Brooke Ratliff, Eric C. Dietze, Gregory R. Bean, Cassandra Moore, Sam Wanko, Victoria L. Seewaldt, Riccardo Ponzone, Nicoletta Biglia, Piero Sismondi, Ernst A. Lien, Per M. Ueland, Per E. Løonning, Vered Stearns, Michael D. Johnson, James M. Rae, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes, Zeruesenay Desta, David A. Flockhart

Research output: Contribution to journalArticle

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)883-885
Number of pages3
JournalJournal of the National Cancer Institute
Volume96
Issue number11
StatePublished - Jun 2 2004

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ratliff, B., Dietze, E. C., Bean, G. R., Moore, C., Wanko, S., Seewaldt, V. L., Ponzone, R., Biglia, N., Sismondi, P., Lien, E. A., Ueland, P. M., Løonning, P. E., Stearns, V., Johnson, M. D., Rae, J. M., Novielli, A., Bhargava, P., Hayes, D. F., Desta, Z., & Flockhart, D. A. (2004). Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine (multiple letters) [1]. Journal of the National Cancer Institute, 96(11), 883-885.